18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 266, Issue 2, 2009, Pages 267-271

  Padovani, Davide ^a   Aimoni, Claudia ^a,d   Zucchetta, Pietro ^b   Paluzzi, Alessandro ^c   Pastore, Antonio ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

18 F fluorodesoxyglucose; Metastatic disease; Positron emission tomography; Unknown primary tumour

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NECK DISSECTION; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 57649220957     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-008-0733-6     Document Type: Article

References (18)

1. E Medini AM Medini CK Lee M Gapany SH Levitt 1998 The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary Am J Clin Oncol 21 121 125 10.1097/00000421-199804000-00004
2. BA Jereczek-Fossa J Jassem R Orecchia 2004 Cervical lymph node metastases of squamous cell carcinoma from an unknown primary Cancer Treatm Rev 30 153 164 10.1016/j.ctrv.2003.10.001
3. JL Abruzzese MC Abruzzese KR Hess 1994 Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients J Clin Oncol 6 1272 1280
4. HJ Steinkamp T Heim BA Zwicker 1992 The value of nuclear magnetic resonance tomography in tumor staging of laryngeal-hypopharyngeal cancer HNO 40 339 345
5. M Benchaud W Lehmann DO Slosman M Becker 1996 The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer Acta Otolaryngol 116 332 335 10.3109/00016489609137852
6. AJ van de Wouw RLH Jansen EJM Speel HFP Hillen 2003 The unknown biology of the unknown primary tumour: a literature review Ann Oncol 14 191 196 10.1093/annonc/mdg068
7. Million RR, Cassisi NJ, Mancuso AA (1994) The unknown primary. In: Million RR, Cassisi NJ (eds) Management of head and neck cancer: a multidisciplinary approach, 2nd edn. Lippincott, PA, pp. 311-321
8. MJ Sack RS Weber GS Wienstien AA Chalian 1998 Image guided fine needle aspiration of the head and neck: five years' experience Arch Otolaryngol Head Neck Surg 124 1155 1161
9. A Courtois H Foehrenbach P Maszelin O de Druille D Garcia 2001 La tomographie à émission de positons en oncologie ORL Ann Otolaryngol Chir Cervicofac 118 4 254 260
10. SAJM van Veen AJM Balm RA Valdés Olmos CA Hoefnagel FJM Hilgers IB Tan FA Pamijier 2001 Occult primary tumors of the head and neck Arch Otolaryngol Head Neck Surg 127 406 411
11. JW Bailet E Abemayor BA Jabour 1992 Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy Laryngoscope 102 281 288
12. J Bailet J Sercrz E Abemayor Y Anzai R Lufkin C Hoh 1995 The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients Laryngoscope 105 135 139 10.1288/00005537-199502000-00004
13. C Nanni D Rubello P Castellucci M Farsad R Franchi S Toso C Barile Nibale O Rampin S Fanti 2005 Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients Eur J Nucl Med Mol Imaging 32 589 592 10.1007/s00259-004-1734-3
14. U Lassen G Daugaard A Eigtved K Damgaard L Friberg 1999 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT) Eur J Cancer 35 1076 1082 10.1016/S0959-8049(99)00077-5
15. H Minn R Paul A Anhonen 1998 Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose J Nucl Med 29 1521 1525
16. U Haberkorn LG Strauss C Reisser D Haag 1991 Glucose uptake perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry J Nucl Med 32 1548 1555
17. D Rades G Kuhnel I Wildfang AR Borner HJ Schmoll W Knapp 2001 Localised disease in cancer of unknown primary: the value of positron emission tomography for individual therapeutic management Ann Oncol 12 1605 1609 10.1023/A:1013107732572
18. N Fakhry T Jacob J Paris M Barberet O Mundler A Giovanni M Zanaret 2006 Apport du TEP scanner au [18F]-FDG dans les adénopathies cervicales primitives Ann Otolaryngol Chir Cervicofac 123 17 25 10.1016/S0003-438X(06) 76634-8